Basic Information
| LncRNA/CircRNA Name | RP11-325I22.2 |
| Synonyms | LINC01511 |
| Region | GRCh38_5:1363582-1380067 |
| Ensemble | ENSG00000250584 |
| Refseq | NR_125810 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung adenocarcinoma |
| ICD-0-3 | C34 |
| Methods | Microarray, qPCR etc. |
| Sample | lung adenocarcinoma tissues |
| Expression Pattern | up-regulated |
| Function Description | RP11-133F8.2 expression of EGFR exon 19 deletions in lung adenocarcinoma was significantly higher than wild-type EGFR tissues, while LOC440905 expression of EGFR exon 19 deletions in lung adenocarcinoma was significantly lower than wild-type EGFR tissues. RP11-325I22.2 and LOC440905 might play an important role in the mechanism of EGFR exon 19 deletion in lung adenocarcinoma. |
| Pubmed ID | 25085781 |
| Year | 2014 |
| Title | LncRNA expression profiles of EGFR exon 19 deletions in lung adenocarcinoma ascertained by using microarray analysis. |
External Links
| Links for RP11-325I22.2 | GenBank HGNC NONCODE |
| Links for lung adenocarcinoma | OMIM COSMIC |